Lawrence Otto Klein Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Lawrence Otto Klein is CBO & COO of CRISPR Therapeutics AG. Currently has a direct ownership of 26,797 shares of CRSP, which is worth approximately $1.21 Million. The most recent transaction as insider was on Jan 02, 2019, when has been sold 20,000 shares (Restricted Stock Units) at a price of $29.87 per share, resulting in proceeds of $597,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.8K
0% 3M change
0% 12M change
Total Value Held $1.21 Million

Lawrence Otto Klein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2019
BUY
Grant, award, or other acquisition
$597,400 $29.87 p/Share
20,000 Added 50.0%
20,000 Restricted Stock Units

Also insider at

DYN
Dyne Therapeutics, Inc. Healthcare
Director
JSPR
Jasper Therapeutics, Inc. Healthcare
Director
LOK

Lawrence Otto Klein

CBO & COO
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP